To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Placental gene expression of inflammatory markers and growth factors: a case control study of obese and normal weight women
Örebro University, School of Health and Medical Sciences, Örebro University, Sweden. Dept Obstet & Gynaecol, Örebro Univ Hosp, Örebro, Sweden.
Örebro University, School of Medicine, Örebro University, Sweden. Dept Paediat, Örebro University Hospital, Örebro, Sweden.
Örebro University, School of Medicine, Örebro University, Sweden. Dept Obstet & Gynaecol, Örebro University Hospital, Örebro, Sweden.
Örebro University, School of Health and Medical Sciences, Örebro University, Sweden. Örebro University Hospital. Dept Obstet & Gynaecol, Örebro University Hospital, Örebro, Sweden.
Show others and affiliations
2015 (English)In: Journal of Perinatal Medicine, ISSN 0300-5577, E-ISSN 1619-3997, Vol. 43, no 2, p. 159-164Article in journal (Refereed) Published
Abstract [en]

Objective: To survey the placental gene expression of inflammatory markers and growth factors in non-smoking obese women with an uncomplicated pregnancy without associated morbidity and delivery at term compared with normal weight women.

Methods: Placental tissue samples from 32 obese women (body mass index, BMI >= 35.0 kg/m(2)) were compared with samples from 94 normal weight women (BMI 18.5-25.0 kg/m(2)) matched for age (+/- 1 year), gestational age (+/- 3 days), parity and mode of delivery. Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to analyse toll receptor-2 and -4, interleukin-6 and -8, tumour necrosis factor-alpha, leptin, adiponectin, insulin-like growth factor-1 and -2, hepatocyte growth factor, hepatocyte growth factor receptor and insulin receptor.

Results: There was no significant difference in gene expression in placental tissue samples from obese and normal weight women.

Conclusion: We found no difference in the occurrence of inflammatory marker and growth factor mRNA levels in placental tissue samples from a large group of obese women without associated morbidity and with healthy infants compared to a closely matched control group of healthy normal weight women. Compared with the previous studies, this anomalous finding may be explained by the absence of associated morbidity in the obese women in our study.

Place, publisher, year, edition, pages
Walter de Gruyter, 2015. Vol. 43, no 2, p. 159-164
Keywords [en]
Obesity, pregnancy
National Category
Gynaecology, Obstetrics and Reproductive Medicine Pediatrics
Research subject
Obstetrics and Gynaecology; Pediatrics
Identifiers
URN: urn:nbn:se:oru:diva-44240DOI: 10.1515/jpm-2013-0343ISI: 000350338000005PubMedID: 25014513Scopus ID: 2-s2.0-84945571575OAI: oai:DiVA.org:oru-44240DiVA, id: diva2:804982
Note

Funding Agency:

Foundation for Medical Research, Orebro University Hospital

Available from: 2015-04-14 Created: 2015-04-14 Last updated: 2025-02-11Bibliographically approved
In thesis
1. Gene expression of inflammatory markers and growth factors in placenta in relation to maternal obesity and foetal and postnatal growth
Open this publication in new window or tab >>Gene expression of inflammatory markers and growth factors in placenta in relation to maternal obesity and foetal and postnatal growth
2020 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Maternal obesity is a growing health problem, that contributes to obstetrical complications in pregnancy, as well as neonatal morbidity and mortality. The placenta serves for gas and nutrient exchange between the mother and the foetus, and obesity may influence and modify placental growth and function. The aims of this thesis were to investigate associations between maternal obesity without associated morbidity and gene expression of inflammatory markers and growth factors in the placenta, as well as offspring birth weight and postnatal growth. 

Study I and III were designed as matched case-control studies including 32 obese women with an early pregnancy body mass index (BMI) ≥ 35.0 kg/m2, study II was an experimental study examining twelve placentas of normal weight women, and study IV was a cohort study including 109 obese women with a BMI ≥ 34.5 kg/m2. In studies I-IV analyses of gene expression were performed and in study III additionally cord blood concentrations were determined. 

No difference was found in the occurrence of placental gene expression of inflammatory markers or growth factors between obese and normal weight women, nor did the sampling site in placentas of normal weight women influence gene expression of these markers, except for leptin gene (LEP) and insulin receptor gene (INSR) expression. Ghrelin gene (GHRL) and LEP expression, as well as cord blood ghrelin and adiponectin levels, was not altered in maternal obesity, and a negatively U-shaped relationship between LEP expression and infant birth weight (BW) z-scores was observed in the placentas of obese women.

In conclusion, no statistically significant difference in gene expressions of inflammatory markers and growth factors in the placenta between severely obese and normal weight women was found. These results are in contrast with earlier studies and could be due to the fact that we examined mainly healthy obese women. The correlations we found between gene expression of leptin in the placenta and the birth weight of the infants warrants further studies.

Place, publisher, year, edition, pages
Örebro: Örebro University, 2020. p. 93
Series
Örebro Studies in Medicine, ISSN 1652-4063 ; 221
Keywords
obesity, pregnancy, placenta, gene expression, cytokines
National Category
Other Basic Medicine
Identifiers
urn:nbn:se:oru:diva-80923 (URN)978-91-7529-354-7 (ISBN)
Public defence
2020-10-16, Örebro universitet, Campus USÖ, hörsal C1, Södra Grev Rosengatan 32, Örebro, 09:00 (Swedish)
Opponent
Supervisors
Available from: 2020-03-31 Created: 2020-03-31 Last updated: 2020-09-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Allbrand, MarianneBjörkqvist, MariaNilsson, KerstinÖstlund, IngridÅman, Jan

Search in DiVA

By author/editor
Allbrand, MarianneBjörkqvist, MariaNilsson, KerstinÖstlund, IngridÅman, Jan
By organisation
School of Health and Medical Sciences, Örebro University, SwedenSchool of Medicine, Örebro University, SwedenÖrebro University HospitalÖrebro University
In the same journal
Journal of Perinatal Medicine
Gynaecology, Obstetrics and Reproductive MedicinePediatrics

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 1554 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf